Skip Navigation


Journal of Biochemistry Advance Access originally published online on March 6, 2009
Journal of Biochemistry 2009 145(6):799-810; doi:10.1093/jb/mvp039
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
145/6/799    most recent
mvp039v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Muraoka, S.
Right arrow Articles by Sugimura, K.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Muraoka, S.
Right arrow Articles by Sugimura, K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Authors 2009. Published by Oxford University Press on behalf of the Japanese Biochemical Society. All rights reserved

Effective Induction of Cell Death on Adult T-Cell Leukaemia Cells by HLA-DRβ-Specific Small Antibody Fragment Isolated from Human Antibody Phage Library

Satoshi Muraoka1, Yuji Ito1,*, Masaki Kamimura1, Masanori Baba2, Naomichi Arima2, Yasuo Suda3, Shuhei Hashiguchi1, Masaharu Torikai4, Toshihiro Nakashima4 and Kazuhisa Sugimura1

1Department of Bioengineering, Faculty of Engineering, Kagoshima University, Korimoto 1-21-40, Kagoshima, Kagoshima 890-0065; 2Center for Chronic Viral Diseases, Graduate School of Medical and Dental Sciences, Kagoshima University, Sakuragaoka 8-35-1, Kagoshima, Kagoshima 890-8544; 3Nanostructured and Advanced Materials Course, Graduate School of Science and Engineering, Kagoshima University, Korimoto 1-21-40, Kagoshima, Kagoshima 890-0065; and 4The Chemo-Sero-Therapeutic Research Institute, Kyokushi, Kikuchi, Kumamoto 869-1298, Japan

*To whom correspondence should be addressed. Tel: +81-99-285-8346, Fax: +81-99-285-8346, E-mail: yito{at}be.kagoshima-u.ac.jp

Received December 19, 2008; Accepted February 23, 2009


   Abstract

By a biopanning method using cell sorter, we quickly isolated an antibody phage clone (S1T-A3) specific to human T-lymphotropic virus type 1-carrying T-cell line S1T from a human single chain Fv (scFv) antibody phage library. This scFv antibody bound to HTLV-1-carrying T-cell lines including MT-2, MT-4 and M8166 other than S1T, but not to non-HTLV-1-carrying T-cell lymphomas such as Jurkat and MOLT4 cells. Interestingly, this antibody induced the cell death on S1T cells very quickly (< 30 min). We tried to identify the target molecules by western blotting and mass spectrometric analysis, revealing that the target antigen was HLA class II DR. The cell death was induced only in dimmer form of scFv (diabody) and at 15-fold lower concentration than that of a fusion protein of scFv and human IgG Fc [(scFv)2-Fc] or anti HLA-DR mouse whole antibody L243. Thus, S1T-A3 diabody is a small antibody fragment with agonistic activity to induce cell death through HLA-DR. This is the first report elucidating that diabody specific to HLA-DR is effective to induce the cell death in T-cell malignancy especially adult T-cell leukaemic cell line.

Key Words: adult T-cell leukaemia, human antibody, scFv, phage library, diabody

Abbreviations: APC, antigen presenting cells; ATL, adult T-cell leukaemia; FACS, fluorescence-activated cell sorter; FBS, fetal bovine serum; FITC, fluorescent isothiocyanate; HLA, human leucocyte antigen; HTLV-1, human T-cell leukaemia virus type 1; mAb, monoclonal antibody; MHC, major histocompatibility complex; PE, phycoerythrin; PI, propidium iodide; RMF, relative mean fluorescence; scFv, single chain Fv; SPR, surface plasmon resonance


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.